BIOMAT Database Logo BIOMAT Database Logo

[PYRAZINAMIDE AND MORPHAZINAMIDE IN THE TREATMENT OF TUBERCULOSIS DUE TO BACILLI RESISTANT TO THE MAJOR ANTIBIOTICS]. 1964

J FOUQUET, and L TEYSSIER

UI MeSH Term Description Entries
D011718 Pyrazinamide A pyrazine that is used therapeutically as an antitubercular agent. Tisamid
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001407 Bacillus A genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic. Bacillus bacterium

Related Publications

J FOUQUET, and L TEYSSIER
[Treatment of tuberculosis due to resistant bacilli].
November 1965, Gazette medicale de France,
J FOUQUET, and L TEYSSIER
[TREATMENT OF PULMONARY TUBERCULOSIS DUE TO RESISTANT BACILLI].
January 1964, Revue de tuberculose et de pneumologie,
J FOUQUET, and L TEYSSIER
[Comparison of the effect of morphazinamide and pyrazinamide in the treatment of chronic tuberculosis].
September 1965, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
J FOUQUET, and L TEYSSIER
[Comparison between morphazinamide and pyrazinamide in retreatment of pulmonary tuberculosis].
September 1965, Minerva medica,
J FOUQUET, and L TEYSSIER
[Tuberculosis due to antibiotic-resistant bacilli; medicosurgical aspects].
March 1958, Le Poumon et le coeur,
J FOUQUET, and L TEYSSIER
[Tuberculosis due to bacilli initially resistant to isoniazid and streptomycin].
January 1966, Revue de tuberculose et de pneumologie,
J FOUQUET, and L TEYSSIER
Pulmonary tuberculosis due to bacilli resistant to streptomycin and isoniazid.
September 1955, Lancet (London, England),
J FOUQUET, and L TEYSSIER
[A case of primo-secondary tuberculosis in adults with malignant development due to Koch bacilli resistant to antibiotics].
January 1968, La Revue lyonnaise de medecine,
J FOUQUET, and L TEYSSIER
[Development of pulmonary tuberculosis due to isoniazid- & streptomycin-resistant bacilli].
January 1958, Giornale italiano della tubercolosi,
J FOUQUET, and L TEYSSIER
Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility.
February 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Copied contents to your clipboard!